Answers are grounded in this paper and cite their sources.
We report 2 patients with transient, focal, repetitive, stereotyped episodes of neurologic deficits during treatment with interleukin-2. One patient had recurrent monocular blindness, while the 2nd had recurrent homonymous quadrantanopia. We suggest that these attacks are provoked by endothelial cell activation induced by interleukin-2.
No takes yet. Share an insight, caveat, or question.
Bernard et al. (1990) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: